These findings are consistent with the previous study, which showed that IC14, an antibody that blocks CD14-mediated LPS binding to TLR4, can downregulate LPS-induced TNF-α [28], and support the previously described mechanism that interaction of LPS with TLR4 promote tumor growth [18]. The gene discussed is CD14; the disease is neoplasm.